An Introduction to Violations, Enforcement, and International Issues in Biologics and Biosimilars
A session from FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More
Recorded March 5–6, 2024
An Introduction to Violations, Enforcement, and International Issues in Biologics and Biosimilars
Learn FDA’s enforcement tools and procedures and the factors FDA weighs when making enforcement decisions. Identify prohibited acts of adulteration and misbranding. Understand international harmonization and import and export regulations.
David L. Chesney, Principal and GM, DL Chesney Consulting, LLC
This session was recorded as part of FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Course in March 2024.
Get Access
-
+$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Virtual Learning FAQ
Related Content